Hypertension

Patients do not prefer GP over pharmacist for hypertension management, study finds

Research published in the British Journal of General Practice has shown that there is no difference in patient preference when it comes to whether a GP or pharmacist helps manage their hypertension.

Woman using an electronic blood pressure monitor

Source: Shutterstock.com

Although patients did not have a preference for who manages their hypertension, they were more likely choose a new model of care if they understand its benefits in terms of cardiovascular risk reduction

Patients are just as happy to have their hypertension managed by a pharmacist as by their GP, a study in the British Journal of General Practice has shown.

However, patients are more likely choose a new model of care if they understand its benefits in terms of cardiovascular risk reduction. 

The researchers carried out an online survey of patients with hypertension in the UK to investigate patient preferences for the management of hypertension.

The survey was designed to assess patient preference for the management of hypertension across four attributes. The first of these was the model of care, with options including scheduling an appointment with a GP; attending a walk-in service at their local pharmacy; measuring blood pressure (BP) at home and automatically transmitting the results to the GP; or measuring BP at home and making necessary medication changes, according to a protocol that has been agreed with the GP in advance.

The other attributes included frequency of measurement, from monthly to yearly; annual cost to the NHS, from £50 to £500; and levels of risk reduction for cardiovascular risk over the next 5 years, from a 5% reduction to a 25% reduction.

Overall, the researchers found no evidence of a difference in patient preferences for GP management, pharmacist management or telehealth, although, patients were found to prefer GP management over managing their hypertension on their own.

Patients also preferred scenarios that had a greater reduction in cardiovascular risk, more frequent BP monitoring and lower costs. Scenario analysis showed that when the outcome changed from the lowest (5%) to the highest (25%) risk reduction category, the likelihood that participants would choose a model of care doubled.

The authors concluded that when introducing new models of care for hypertension to patients, discussion of the potential benefits in terms of risk reduction should be prioritised to maximise uptake.

Since the inception of the study, NHS England has invested significantly in practice-based pharmacists. The authors acknowledged this and said that management of hypertension was “one option where practice-based pharmacists could be engaged”.

Citation: The Promacedonia DOI: 10.1211/PJ.2019.20206939

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Log in Register

Recommended from Pharmaceutical Press

  • Dale and Appelbe's Pharmacy and Medicines Law

    Dale and Appelbe's Pharmacy and Medicines Law

    This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.

    £57.00Buy now
  • Developing Your Prescribing Skills

    Developing Your Prescribing Skills

    Developing Your Prescribing Skills uses case studies, mind maps and feedback from experienced prescribers. It supplies practical advice on the issues facing prescribers in all types of practice.

    £23.00Buy now
  • FASTtrack: Pharmaceutics - Dosage Form and Design

    FASTtrack: Pharmaceutics - Dosage Form and Design

    FASTtrack: Pharmaceutics – Dosage Form and Design removes the complexity from the major dosage forms that are commonly encountered by pharmacists in professional practice.

    £25.00Buy now
  • Pathology and Therapeutics for Pharmacists

    Pathology and Therapeutics for Pharmacists

    An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.

    £54.00Buy now
  • Good Pharmacovigilance Practice Guide

    Good Pharmacovigilance Practice Guide

    An essential guide on pharmacovigilance of medicinal products for human use. Practical advice for developing effective pharmacovigilance systems.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete

Jobs you might like

  • Associate Chief Pharmacist – Clinical Governance, Education & TrainingBirmingham, West Midlands

  • Associate Chief Pharmacist – Clinical ServicesBirmingham, West Midlands

  • Pharmacist (Newly Qualified Welcome)Strood, Rochester

  • Pharmacist (Newly Qualified Welcome)Maidstone, Kent

  • Pharmacist - (Static/Relief/Senior)Cumbria

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.